Olba Healthcare Holdings, Inc. · TSE:2689
Olba Healthcare — Q2 FY6/2026 Earnings Presentation
55 slides from Olba Healthcare's earnings presentation, February 2026
Slide 1: Financial Results Report Q2 FY06/2026
Financial Results Report Q2 FY06/2026 OLBA HEALTHCARE HOLDINGS, INC. (formerly Kawanishi Holdings Inc.) This presentation includes machine translation. Please consider that some content may not be perfectly accurate or contextually appropriate. ( Security :2689)
Slide 2: Contents
Contents ◆ Corporate Philosophy ◆ Overview of Q2 FY6/26 Business Performance ◆ FY6/26 Results Forecast and Basic Policy on Dividends ◆ Outline of Medium-term Business Plan ◆ Reference material
Slide 3: Corporate Philosophy
Corporate Philosophy oo OLBA HEALTHCARE
Slide 4: Corporate Philosophy and Origin of OLBA Healthcare
Corporate Philosophy and Origin of ""OLBA Healthcare"" Aiming to develop medical science, medical care, and long-term nursing care through our business endeavors OVAL ORBIT An ellipse connected as one Orbit In regional healthcare, people and technology are connected, aiming for a future where they f
Slide 5: FY06/2026 Overview of Results for 2nd quarter
FY06/2026 Overview of Results for 2nd quarter
Slide 6: Domestic Market Size of Medical Devices
Domestic Market Size of Medical Devices Stable market growth despite medical expenses reduction policy Forecast of ¥3,895 billion for FY2025 ・The market has recovered from the impact of COVID-19 and is expanding steadily ・Market size is expanding due to increased surgeries and introduction of new pr
Slide 7: Recent Market Environment and Our Response Policy [Q2]
Recent Market Environment and Our Response Policy [Q2] ■Global Inflation and Weak Yen ・Prices of medical devices, many of which are imported, continue to rise ⇒Implementing measures such as expanding sales activities and improving procurement ⇒Conducting negotiations to pass on costs to sales prices
Slide 8: Performance Topics: Our Current State [Q2]
Performance Topics: Our Current State [Q2] ■Sluggish Operating Profit Growth in Core Medical Equipment Business ・Sales are growing steadily, but profit margins are declining due to tough price negotiations ⇒Orthopedic field performing well due to customer acquisition in the Kansai area ⇒Postponement
Slide 9: Q2 FY6/26 Consolidated Results [Q2]
Q2 FY6/26 Consolidated Results [Q2] Sales and gross profit reached record highs, but profits declined from the previous Millions of Yen vs. Budget year sales 62,444 △1.4% +3.0% Gross Profit 6,940 △4.1% +1.8% Gross Margin 11.11% △0.32 △0.13 SG & A Expenses 6,267 △2.7% +4.3% Income from Operations 673
Slide 10: Medical and Nursing Care Equipment Sales Business: Business Description
Medical and Nursing Care Equipment Sales Business: Business Description ② share of total net sales [Q2 FY6/26] Sales (Operating Income) *Sales include inter-segment sales Medical Equipment SPD Nursing Care Products 58 58.9billion Medical Equipment Business 2.3% (0.55 billion) Total partner for medic
Slide 11: Medical Equipment Business
Medical Equipment Business Total partner for medical settings Medical Equipment [92.9%] from the Millions of Yen Actual results vs. Budget previous year ※1 sales 58,922 △1.4% +2.8% sales Income from component 555 △21.1% △22.4% ratio Operations ※2 from the previous Millions of Yen Sales Results year
Slide 12: Medical Equipment Business: Consumables
Medical Equipment Business: Consumables Sales 53.4 billion, up 2.7% YoY Millions of Yen CLASSIFICATION OF from the sales Sub-segment Highlights GOODS previous year Increased surgeries; diabetes-related products, a key initiative, are selling well Surgery-related Consumables 26,142 +0.7% Internal med
Slide 13: Medical Equipment Business: Equipment and Fixtures
Medical Equipment Business: Equipment and Fixtures Sales 6.4 billion, down 1.6% YoY Key Points of Equipment and Fixtures Sales ◆Demand increase from COVID-19 subsidies has subsided ◆Investment appetite has declined due to deteriorating hospital management conditions ◆Sales of automatic fare adjustme
Slide 14: SPD Business
SPD Business HOSNET-JAPAN INC. Specialist in Medical Materials Distribution from the Millions of Yen Actual results vs. Budget previous year sales ※ 3,027 +1.6% +6.5% Materials Information Purchase Management management Management Income from 64 +21.2% +16.9% Operations Total Number of *Sales (inclu
Slide 15: Nursing Care Products Business
Nursing Care Products Business Life Care Co., Ltd. Total support for nursing care products from the Millions of Yen Actual results vs. Budget previous year sales ※ 1,460 +0.4% +6.6% Rental Sales Renovation Income from 122 +8.4% +16.2% Operations *Sales (including vs. budget and YoY) include inter-se
Slide 16: FY6/26 Results Forecast and Basic policy on dividends
FY6/26 Results Forecast and Basic policy on dividends
Slide 17: FY6/26 Full-Year Consolidated Results Forecast
FY6/26 Full-Year Consolidated Results Forecast Sales and gross profit are expected to set new record highs, with a slight rise in operating income (Millions of Yen) forecast 2025/6 Result Increase/Decrease sales 127,978 122,702 +4.3% Gross Profit 14,856 13,909 +6.8% Gross Margin 11.61% 11.34% +0.27
Slide 18: FY6/26 Operating Profit Change Factors
FY6/26 Operating Profit Change Factors (Millions of Yen) 【 primary reason for variations 】 3,000 ・Further market development in the Kansai area ・SG&A increase due to continued investment in Medical Equipment Business personnel and systems 2,800 239 Nursing Care SPD Business 2,600 Products Business 4
Slide 19: Net sales: Forecast to reach record high
【 Net sales 】 Forecast to reach record high Sixth consecutive year of revenue growth, FY6/26 forecast of 127.9 billion (up 4.3% YoY) reaching record high (Millions of Yen) 160,000 127,978 122,702 118,564 120,000 107,959 110,472 80,000 60,627 62,444 57,466 53,030 53,718 40,000 0 Half Year Full Year H
Slide 20: Operating Income: Forecast for slight rise
【 Operating Income 】 Forecast for slight rise in operating income Forecast of 2.0 billion yen for FY06/26 Aiming to recover to the 2.0 billion yen level this ( Up 1.0% year-on-year ) fiscal year 2,500 (Millions of yen) 2,226 2,151 2,073 1,979 2,000 2,000 1,500 1,000 854 808 786 746 673 500 0 Half Ye
Slide 21: Basic policy on dividends
Basic policy on dividends ① We aim to increase or maintain dividends ② We strive to build retained earnings to provide resources for growth Forecast of 80 yen for FY06/26 investment Dividend per stock [Dividend Status for the Past 10 Years] dividends on equity (DOE) ratio Dividend yield 5.0% 4.0% 4.
Slide 22: Cost of capital and capital profitability: Current analysis
Cost of capital and capital profitability: Current analysis ROE・Cost of equity capital trends 20.0% ・Equity spread (%) 18.0% 17.8% (ROE - cost of equity capital) ⇒Approximately 6% to 7% 16.0% 13.8% 14.0% ・Continuously achieving capital profitability 12.0% 12.8% 14.6% 12.1% that exceeds the cost of c
Slide 23: Initiatives to improve PBR
Initiatives to improve PBR net profit to sales Improving productivity through efficiency gains via DX, etc. (1.17%) Promoting high value-added new businesses ROE Total Asset Turnover Appropriate receivables collection and inventory management (12.1%) (2.8x) Strengthening of the capital base in line
Slide 24: Outline of medium-term management plan
Outline of medium-term management plan
Slide 25: VISION2030 Initiatives for Sustainable Growth and Shareholder Returns
VISION2030 Initiatives for Sustainable Growth and Shareholder Returns VISION 2030 Japan's highest level medical More than 30 new products 20% of operating profit from overseas device trading company and services [Main Market] 【 Growth strategy 】 【 Shareholder return 】 Medical and nursing care indust
Slide 26: Medium-Term Management Plan Overview
Mid-term management scheme (FY06/28: Net sales of 142.0 billion yen, Operating profit of 2.7 billion yen) Key Points of the 2026/6-2028/6 Medium-Term Management Plan OLBA-DX Productivity improvement Strengthen and streamline operations Sophistication of Develop new regions and CRM/SFA/BI constructio
Slide 27: Medium-Term Management Plan: Key Initiative Points
Medium-Term Management Plan: Key Initiative Points ➢ OLBA-DX : Improving sales quality through operational efficiency and ICT tool utilization Also working to improve employees' IT skills ➢ Productivity improvement: Strengthening current operations and logistics innovation (construction of new distr
Slide 28: OLBA-DX Reform by DX Promotion Office
OLBA-DX Reform by DX Promotion Office OLBA-DX [In-house no-code tool utilization study session] Status of DX initiatives ➢ Promoting further sales support and operational efficiency ・Expansion of generative AI use ・Expansion of no-code tool utilization ・CRM and SFA development: Proof of concept stag
Slide 29: Logistics Innovation
logistics Innovation Logistics Innovation Distribution warehouse construction ● Launch of integrated distribution system ""Li-Flo"" Operation started sequentially from operating company Kawanishi's sites from September 2022 ⇒ Planned completion of rollout to entire group reinforcement in to reinforc
Slide 30: Proof of concept for joint delivery of medical devices in Kurashiki
logistics Innovation Proof of concept for joint delivery of medical devices in the Kurashiki area Background and Objectives Medical device sales company in the Okayama area ・Addressing the logistics 2024 problem and driver shortages ・Eliminating low loading rates and inefficiencies in medical device
Slide 31: New Business 1: TEMASAC sales performing well
New business development New Business ① ""TEMASAC®"" sales performing well BARCMED business expansion Automatic payment machine ""TEMASAC®"" series for clinics Eligible for IT Introduction Subsidy Receipt computer integration, ●Introduction results for July-December 2025: 147 units Cashless payment
Slide 32: New Business 2: Establishment of OLSEED Co., Ltd.
(January 6, 2025) New business development New Business ② Establishment of OLSEED Co., Ltd. Reducing the burden on the environment Joint development with Osaka University Low-temperature decomposition upcycle unit ""OLSTECH®"" Environmental Safety Research Management Center OLSTECH| 3 Features 1) Si
Slide 33: New Business 3: Babyeets
new business③ 「Babyeets®」 New business development Newborn Live Streaming & Memorial Movie Creation Service ""Babyeets®"" Babyeets®| 3 Features 01 Easy operation requiring only to read a dedicated card 02 Real-time video viewing from remote locations 03 Memorial video provided after discharge [Thoug
Slide 34: Thai OLBA Healthcare Business
Development of New Businesses Thai OLBA Healthcare Business (From January 2023) Development of ASEAN Business Rental Commencement of Business progress Rehabilitation Equipment Sales expansion of fully automatic tablet Morito Co., Ltd.'s Weight-bearing Gait Lift packaging machines THAI MORITOH Weight
Slide 35: ESG Initiatives
ESG Initiatives Sustainability Social Governance Environment ( Social Relations ) ・Ensuring management transparency, efficiency, and soundness. Increase the Value of the Group ・Sales of low-temperature pyrolysis upcycling unit ""OLSTECH®"" ・The Employee Charter states ""Always [Human Capital Investm
Slide 36: Initiatives for Improving the Internal Environment
Initiatives for Improving the Internal Environment Sustainability Promoting Diversity ➢ Women's Active Participation ➢ Encouraging Male Employees to Take Child- ・Announced target of 19.0% female managerial staff ratio rearing Leave by 2030 ・Raising awareness through maternity/childcare leave ・Starte
Slide 37: Source of Growth: Human Resource Development
Source of Growth: Human Resource Development Building Expertise and ◼ Systematic Human Resource Development and Acquisition of Expertise Management Skills In-house education program ""OLBA Academy"" with 30 years of history e-Learning courses are also being expanded sequentially Learning opportuniti
Slide 38: Strengths and Utilization, Weaknesses and Countermeasures
Our ""Strengths and Utilization"" and ""Weaknesses and Countermeasures"" Strengths and Utilization ➢ No.1 market share in the Chugoku-Shikoku region (based on trust from customers and suppliers) ⇒New investments are possible through securing stable earnings ➢ Human resource development and DX invest
Slide 39: SPD Business
HOSNET-JAPAN INC. SPD Business ● Acquiring new customers, improving profitability ・Opening centers in Shikoku and expanding existing centers ・Customer development in the Chugoku-Shikoku area ・Hospital management support proposals such as purchasing price reduction and insurance claim verification ●
Slide 40: Nursing Care Equipment Business
Nursing Care Equipment Business Life Care Co., Ltd. ● Increasing market share in existing areas ● In-house construction of nursing care home renovations ・Strengthening customer service through enhanced ・Developing new users follow-up system ・Providing safe and secure services ・Promoting sales activi
Slide 41: Reference material
Reference material oo OLBA HEALTHCARE
Slide 42: Company Profile
Company Profile Name: OLBA HEALTHCARE HOLDINGS, INC. (Former name: Kawanishi Holdings Co., Ltd.) Head Office: 1-1-3 Shimoishii, Kita-ku, Okayama City Founded: May 1921 Kawanishi BarcMed Co., Ltd. Established: October 1967 Kawanishi Co., Ltd. Representative: President and CEO Yohei Maejima Sansei Med
Slide 43: History
History May 1921 Founded Kawanishi Kikai-ten in Daiunji-cho, Okayama City (currently Chuo-cho, Kita-ku, Okayama City). September 1927 Reorganized and established as Kawanishi Kikai-ten Limited Partnership. June 1950 Reorganized and established as Kawanishi Kikai-ten Co., Ltd. (Yugen-kaisha). October
Slide 44: OLBA Group Employee Charter
OLBA Group Employee Charter Business Vision ○ Contribute to the development of medicine, healthcare, and nursing care through business, and contribute to the health and longevity of the people ○ Promptly and appropriately provide the benefits of innovative new functions and technologies to patients
Slide 45: Consolidated Balance Sheet (Q2 FY6/26)
Consolidated Balance Sheet (Q2 FY6/26) Millions of Yen Increase/Dec Liabilities and Net Increase/Dec Identifiable assets price price rease Assets rease Cash and cash Accounts payable 28,180 1,137 2,906 △563 equivalents Short-term Trade receivables 27,679 1,309 2,350 1,950 borrowings Product 7,395 97
Slide 46: Consolidated Statements of Cash Flows (Q2 FY6/26)
Consolidated Statements of Cash Flows (Q2 FY6/26) FY6/25 FY6/26 Millions of Yen Second Quarter Second Quarter Income before Income Taxes 815 694 Depreciation expenses 289 350 Impairment losses on fixed assets 11 - Decrease (increase) in trade receivables △1,711 △1,309 Decrease (increase) in inventor
Slide 47: Consolidated Statements of Cash Flows (Q2 FY6/26)
Consolidated Statements of Cash Flows (Q2 FY6/26) FY6/25 FY6/26 Millions of Yen Second Quarter Second Quarter Net increase (decrease) in short-term borrowings 2,100 1,950 Payments for repayment of long-term debt - △200 Payment of lease obligation △76 △75 Payment for purchase of treasury stock △135 -
Slide 48: Key Consolidated Management Indicators 1
Key Consolidated Management Indicators ① Items Unit 2021/6 2022/6 2023/6 2024/6 2025/6 Millions of sales Yen 102,072 107,959 110,472 118,564 122,702 Millions of Income from Operations Yen 1,540 2,073 2,151 2,226 1,979 Millions of Current Profit Yen 1,542 2,119 2,158 2,244 1,962 Net income attributab
Slide 49: Key Consolidated Management Indicators 2
Key Consolidated Management Indicators ② Items Unit 2021/6 2022/6 2023/6 2024/6 2025/6 Millions of Operating cash flow Yen 3,126 2,420 △659 2,084 1,626 Cash flows from investing Millions of Yen △630 △211 △306 △673 △1,635 activities Cash flows from financing Millions of Yen △2,262 △1,169 175 △1,089 6
Slide 50: (Previous fiscal year) Consolidated Results for FY6/25
(Previous fiscal year) Consolidated Results for FY6/25 Net sales reached a record high, but profits declined from the previous Millions of Yen vs. Budget year sales 122,702 △0.8% +3.5% Gross Profit 13,909 △3.7% +2.3% Gross Margin 11.34% △0.34 △0.14 SG & A Expenses 11,929 △2.0% +4.9% Income from Oper
Slide 51: FY6/25 Financial Results Summary
(Previous fiscal year) FY6/25 Financial Results Summary ※New highs for net sales sales ROE Dividend yield ¥122.7 billion 12.1% 4.0% ( YoY change +3.5%) (5-year average 14.2%) (*As of June 30, 2025) Income from Operations PBR DOE Dividends on Equity ¥1.97 billion 0.97 times 4.0% ( YoY change △11.1%)
Slide 52: CSR Initiatives: Community-Based Social Contribution
CSR Initiatives: Community-Based Social Contribution Walking together with the local community toward a future that leads to regional development and vitalization Fagiano Okayama MedTech Angels Club Sponsor Health-tech venture support Established in 2006, the first professional soccer club in Okayam
Slide 53: MINC Society Study Session on Latest Trends in Overseas Medical Devices
Japan Medical and Engineering Manufacturing Commons MINC Society ""Study Session on Latest Trends in Overseas Medical Devices"" Featured in Medical Globe Sharing information and holding discussions across multiple industries on the latest overseas medical device information Physicians, manufacturers
Slide 54: Company Information and Contact
Company Information and Contact 【 Fiscal year 】 July 1 to June 30 of the following year 【 Annual Meeting 】 Held in September every year [Stock Exchange Listing] Tokyo Stock Exchange (Standard Market) Security 2689 【 Share Unit 】 100 shares 【 Key contacts 】 OLBA Healthcare Holdings, Inc. Managing Dir
Slide 55: ・While every effort has been made to ensure the accuracy of the information provided
・While every effort has been made to ensure the accuracy of the information provided in this document, we do not guarantee its accuracy or completeness. ・The opinions and forecasts contained in this document represent our outlook based on information available at the time of preparation, and we do n
OLBA Healthcare Holdings — Q2 FY6/2026 Earnings Presentation on 6ix